Insomnia Treatment: DORAs Aid Benzodiazepine Tapering, Acupuncture Review

Discontinuing benzodiazepines and related sleep medications is one of the hardest steps in insomnia treatment — and a 2026 insurance claims analysis from Japan suggests dual orexin receptor antagonists (DORAs) may help patients taper off these drugs successfully. Meanwhile, a critical review of acupuncture evidence finds the technique improves subjective sleep quality but lacks proof on objective sleep measures. Together, these studies sketch the current state of insomnia pharmacotherapy: shifting targets, honest limits, and practical options for real patients.

Orexin Antagonists as a Bridge Off Benzodiazepines

Benzodiazepines and benzodiazepine receptor agonists — the latter including Z-drugs like zolpidem and eszopiclone — carry risks of dependence, cognitive impairment, and falls, especially with long-term use. Stopping them is notoriously difficult. A mirror-image analysis of Japanese insurance claims data by Kazuomi Matsui of the National Center of Neurology and Psychiatry in Tokyo and colleagues examined whether initiating a DORA changes benzodiazepine use patterns afterward.

The logic is mechanistic rather than merely substitution-based. Benzodiazepines act broadly on GABA-A receptors, dampening neural activity across wide regions of the brain. DORAs work differently: they block orexin (also called hypocretin), a neuropeptide produced in the lateral hypothalamus that stabilizes wakefulness. By quieting the brain’s wake-promoting signal rather than globally sedating the brain, DORAs reduce daytime carryover effects and — critically — appear to lack the dependence liability of GABAergic drugs.

The mirror-image design compares each patient’s medication use before and after DORA initiation, controlling for individual baseline differences. The findings support DORA-assisted dose reduction of BZ/BZRAs, adding to a growing body of evidence reviewed in our coverage of how orexin blockers compare with conventional sleeping pills and 6-month long-term DORA safety data. Claims data have limits — no polysomnography, no direct clinician assessment — but they capture real-world prescribing at scale.

Acupuncture: Strong Subjective Signal, Weaker Physiological Proof

A critical narrative review by Ming and colleagues at Chongqing Three Gorges Medical College, published in Frontiers in Neuroscience, took a rigorous look at acupuncture and related acupoint stimulation for insomnia disorder. Their question was more demanding than “did patients feel better?” They asked whether acupuncture can serve as a testable model of sleep-wake and hyperarousal circuitry.

The clinical signal is consistent on one dimension: subjective sleep quality and insomnia severity improve in selected populations. But the evidence thins out from there. Objective sleep architecture measured by polysomnography, multiday sleep-wake stability, relapse prevention, and biomarkers predicting who responds — all remain insecure. Human neuroimaging points to plausible circuitry: the locus coeruleus (the brain’s main norepinephrine hub, which drives arousal), hypothalamic regions, the insula, limbic-prefrontal pathways, and thalamocortical networks. These are the same regions implicated in chronic insomnia’s hyperarousal physiology — interesting, but still associative rather than causal.

Proposed mechanisms span electrophysiological, autonomic, endocrine, neurochemical, and even microbiota-gut-brain pathways. Each is biologically plausible; none is firmly tied to human chronic insomnia. Their conclusion: acupuncture should be treated as an adjunctive, preference-sensitive option — not a replacement for CBT-I.

What This Means for Choosing Treatment

The two studies converge on a shared theme: insomnia treatment is moving toward targeted, mechanism-informed options while acknowledging the limits of current evidence. For patients stuck on long-term benzodiazepines, DORAs offer a pharmacologically rational off-ramp — blocking wakefulness rather than flooding the brain with inhibitory signaling. For patients drawn to non-drug approaches, acupuncture delivers measurable symptom relief for some, though safety reporting is inconsistent across trials and cost-effectiveness data against CBT-I or medication simply do not exist yet.

CBT-I remains the reference standard because it produces durable improvement without medication. Medication decisions should account for comorbidities too — see our reporting on cardiac interactions with insomnia drugs and the underlying role of orexin as the brain’s master sleep-wake switch.

Practical Applications

• If you have used benzodiazepines or Z-drugs for months or years, ask a sleep physician about a DORA-supported taper; abrupt discontinuation risks rebound insomnia and withdrawal.
• Try CBT-I first for chronic insomnia — it outperforms medication for long-term durability, and any drug or acupuncture approach works best layered on top of it.
• If you pursue acupuncture, track outcomes with a sleep diary and validated measures like the Insomnia Severity Index rather than relying on general impressions.
• Keep expectations calibrated: acupuncture may improve how you sleep and feel; it has not yet been shown to normalize objective sleep architecture.
• Report adverse events from any treatment to your clinician — underreporting in acupuncture trials means the safety picture is incomplete.

Frequently Asked Questions

Can orexin antagonists help me stop taking sleeping pills?

Emerging claims-data evidence suggests DORAs can support gradual benzodiazepine and Z-drug dose reduction, but tapering should always be medically supervised to avoid withdrawal and rebound insomnia.

Is acupuncture as effective as sleeping pills for insomnia?

Acupuncture reliably improves subjective sleep quality and insomnia severity in selected patients, but unlike medications such as DORAs, it lacks robust evidence for changing objective sleep architecture.

Why are orexin antagonists considered safer than benzodiazepines?

DORAs block a specific wake-promoting neuropeptide system rather than broadly enhancing GABA signaling, which reduces dependence liability and daytime cognitive carryover.

Should acupuncture replace CBT-I?

No. The Frontiers in Neuroscience review explicitly recommends positioning acupuncture as an adjunctive, preference-sensitive option rather than a substitute for cognitive behavioral therapy for insomnia.

Sources:
https://pubmed.ncbi.nlm.nih.gov/42719845/
https://pubmed.ncbi.nlm.nih.gov/42717137/
https://pubmed.ncbi.nlm.nih.gov/42715944/
https://pubmed.ncbi.nlm.nih.gov/42648126/
https://pubmed.ncbi.nlm.nih.gov/42546895/